These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7399245)

  • 21. Inhibition of hepatitis B virus replication by recombinant small interfering RNAs.
    Wu K; Gong Y; Zhang X; Zhang Y; Mu Y; Liu F; Song D; Zhu Y; Wu J
    Acta Virol; 2005; 49(4):235-41. PubMed ID: 16402680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
    Walter E; Keist R; Niederöst B; Pult I; Blum HE
    Hepatology; 1996 Jul; 24(1):1-5. PubMed ID: 8707245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.
    Guido M; Thung SN; Fattovich G; Cusinato R; Leandro G; Cecchetto A; Cesaro S; Panese P; Rugge M
    Mod Pathol; 1999 Jun; 12(6):599-603. PubMed ID: 10392636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A rare etiology for HBs-Ag negative acute hepatitis B--coinfection by hepatitis B and delta].
    Körner T; Jaspersen D; Roth J; Hammar CH; Bässler R
    Leber Magen Darm; 1994 Sep; 24(5):215-7. PubMed ID: 7968181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease.
    Mason A; Theal J; Bain V; Adams E; Perrillo R
    Am J Gastroenterol; 2005 Apr; 100(4):972-6. PubMed ID: 15784044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
    Lu SC; Yan LN; Li B; Ma YK; Liu C; Wen TF; Lin QY; Zhao JC; Wang XB; Li XD; Qing S; Zhao LS; Liu C; Liu J; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):196-201. PubMed ID: 14599968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.
    Pan XB; Wei L; Chen HS; Liu F; Gao Y
    Arch Virol; 2007; 152(6):1159-73. PubMed ID: 17308979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
    Manegold C; Hannoun C; Wywiol A; Dietrich M; Polywka S; Chiwakata CB; Günther S
    Clin Infect Dis; 2001 Jan; 32(1):144-8. PubMed ID: 11118394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient.
    González-Peralta RP; Andres JM; Tung FY; Fang JW; Brunson ME; Davis GL; Lau JY
    Transplantation; 1994 Jul; 58(1):114-6. PubMed ID: 8036699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
    Huang YQ; Wang LW; Yan SN; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease.
    Osborn MK; Guest JL; Rimland D
    HIV Med; 2007 Jul; 8(5):271-9. PubMed ID: 17561872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: are they really "off the hook"?
    McMahon BJ
    Hepatology; 1998 Jul; 28(1):265-7. PubMed ID: 9657122
    [No Abstract]   [Full Text] [Related]  

  • 38. Late effects of acute phase hepatitis B sera in continuous cell lines.
    Rosin S; Cajal N
    Virologie; 1981; 32(3):249-51. PubMed ID: 7303495
    [No Abstract]   [Full Text] [Related]  

  • 39. [Structure and replication mechanisms of hepatitis B virus].
    Utsumi T; Hotta H
    Nihon Rinsho; 2011 May; 69 Suppl 4():344-9. PubMed ID: 22096942
    [No Abstract]   [Full Text] [Related]  

  • 40. [An attempt to identify HBsAg in bile and gastric contents].
    Vuković B; Mudrić V
    Vojnosanit Pregl; 1977; 34(5):332-3. PubMed ID: 602058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.